Position in PCRX
as of Mar 31, 2026
· filed Jun 18, 2026
Position Value
$5,320,650
+$425,630 QoQ
Shares Held
235,427
+24.5% QoQ
Ownership
0.598%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Pacer Advisors, Inc. holds $370,550,834 across 18 Drug Manufacturers - Specialty & Generic names. PCRX ranks #9 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
243,545 | $144,417,314 | |
| 2 | VTRS |
Viatris Inc
|
8,033,876 | $108,537,664 | |
| 3 | ALKS |
Alkermes plc.
|
688,563 | $24,347,587 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
169,230 | $22,294,360 | |
| 5 | ZTS |
Zoetis Inc.
|
165,570 | $19,572,029 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,563,040 | $14,880,140 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
256,365 | $8,477,990 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
85,467 | $6,572,412 |
All Filings in PCRX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,320,650 | 235,427 | Shares | Sole | 2026-06-18 | |
| 2025-12-31 | $4,895,020 | 189,143 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $5,159,205 | 200,202 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $9,240,433 | 386,629 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $14,951,449 | 601,668 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $61,471,849 | 3,262,837 | Shares | Sole | 2025-01-22 | |
| 2024-12-31 | $61,471,849 | 3,262,837 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $74,681,426 | 4,962,221 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $61,877,336 | 2,162,787 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $45,954,440 | 1,572,705 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $35,146,249 | 1,041,679 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $8,038 | 262 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,899 | 272 | Shares | Sole | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||